Glaucoma
📧 Sign up to get email alerts when something new happens for Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Triamcinolone Injections for Persistent Choroidal Effusions Post Glaucoma Surgery [Phase 4]
A Phase 4 trial investigating Triamcinolone injections for persistent choroidal effusions after glaucoma surgery.
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT [Phase 4]
Phase 4 clinical trial update comparing latanoprost preserved vs unpreserved on tear film thickness measured by OCT in glaucoma and ocular h…
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Ahmed Valve Implantation Coated With Poly Lactic -Co-glycolic Acid (PLGA) Saturated With Mitomycin-C in the Management of Adult Onset Glaucoma in Sturge Weber Syndrome [Phase 3]
Phase 3 clinical trial evaluating Ahmed Valve implantation coated with PLGA saturated with mitomycin-C for adult-onset glaucoma in Sturge-We…
-
FDA approval · 2022-04-04FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Sandoz Inc)
FDA approves Sandoz Inc's original ANDA for a fixed-dose combination of brimonidine tartrate and timolol maleate to lower intraocular pressu…
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study [NA]
A completed clinical trial from Wills Eye on telemedicine-based detection and follow-up for glaucoma-related conditions; results posted in 2…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-03-08FDA Approved: LUMIGAN — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Lumigan (bimatoprost) submitted by Allergan, Inc., resulting in an updated label for the pro…
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing Bimatoprost SR to selective laser trabeculoplasty in open-angle glaucoma or ocular hypertension has completed with r…
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Comparative Study of the NIDEK TONOREF III and the Haag-Streit Goldmann Manual Tonometer and Comparison of Pachymetry Values for NIDEK TONOREF III With the NIDEK CEM-530
A completed clinical trial comparing the NIDEK TONOREF III tonometer with the Haag-Streit Goldmann manual tonometer and evaluating pachymetr…
-
FDA approval · 2022-01-31FDA Approved: BRIMONIDINE TARTRATE — Original Application (Apotex Corp.)
FDA approved the original application for brimonidine tartrate from Apotex Corp, a generic product used to lower intraocular pressure in gla…
-
FDA approval · 2022-01-27FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved the original generic application for dorzolamide hydrochloride from Sagent Pharmaceuticals. The topical solution is used to low…
-
FDA approval · 2022-01-25FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Original Application (Micro Labs Limited)
FDA approved the preservative-free fixed-dose combination of dorzolamide hydrochloride and timolol maleate under Micro Labs Limited's origin…
-
FDA approval · 2021-12-03FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd.)
FDA approved a supplemental application for dorzolamide hydrochloride submitted by Advagen Pharma Ltd. The action reflects an approved suppl…
-
FDA approval · 2021-11-17FDA Approved: TIMOPTIC — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for TIMOPTIC (timolol maleate) submitted by Bausch & Lomb Incorporated.
-
CLINICAL_TRIALS withdrawal · 2021-11-17Clinical Trial Update: PREFERENTIAL Study [Phase 2, Phase 3]
A clinical trial update shows the PREFERENTIAL study (Phase 2/3) has been withdrawn.
-
FDA approval · 2021-10-28FDA Approved: PHOSPHOLINE IODIDE — Supplemental Application (Fera Pharmaceuticals, LLC)
FDA approved a supplemental application for phospholine iodide (echothiophate iodide for ophthalmic solution) from Fera Pharmaceuticals, LLC…
-
CLINICAL_TRIALS trial_result · 2021-10-21Clinical Trial Update: Influence of Glidescope Assisted Endotracheal Intubation on Intraocular Presure [Phase 4]
Phase 4 clinical trial evaluating whether GlideScope-assisted endotracheal intubation affects intraocular pressure.
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: The American Glaucoma Society (AGS) Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS) [NA]
A terminated clinical trial comparing an aqueous shunt implant to transscleral cyclophotocoagulation for glaucoma; results were posted.
-
CLINICAL_TRIALS trial_result · 2021-10-08Clinical Trial Update: Treatment Outcomes of MicroPulse Trans-scleral Cyclophotocoagulation in Uncontrolled Glaucoma [NA]
Clinical trial update reporting outcomes of MicroPulse trans-scleral cyclophotocoagulation in uncontrolled glaucoma; study completed with re…
-
FDA approval · 2021-08-23FDA Approved: LATANOPROST — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for LATANOPROST from Sandoz Inc., indicating an approved modification related to this generic produc…
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: Nailfold Capillary Blood Flow With Latanoprost Bunod [Phase 4]
Phase 4 trial update evaluating nailfold capillary blood flow with latanoprost bunod in open-angle glaucoma has completed; results posted in…
-
FDA approval · 2021-08-19FDA Approved: ACETAZOLAMIDE — Original Application (Advagen Pharma Ltd)
FDA approved Advagen Pharma Ltd's generic acetazolamide under an original (ANDA) application, enabling marketing of a generic formulation of…
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery [Phase 3]
Phase 3 trial evaluating bevacizumab as a modulator of wound healing after trabeculectomy for glaucoma.
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: H-1337 Ophthalmic Solution Phase 1/2 [Phase 1, Phase 2]
Phase 1/2 study of H-1337 ophthalmic solution for glaucoma (open-angle) completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-14Clinical Trial Update: Clinical Study of the Safety and Performance of the Miami InnFocus Drainage Implant to Relieve Glaucoma Symptoms [NA]
Clinical trial update completed for the Miami InnFocus Drainage Implant assessing safety and performance in glaucoma; results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Changes in Corneal Endothelial Cell Density After Transscleral ab Interno Glaucoma Gel Stent Implantation
Completed clinical trial evaluating corneal endothelial cell density after transscleral ab interno glaucoma Gel Stent implantation.